Management Team
Stephen R. Davis
Chief Executive Officer
Serge Stankovic, M.D., M.S.P.H.
President
Gudarz Davar, M.D.
Executive Vice President and Head of Research and Development
Austin D. Kim
Executive Vice President,
General Counsel and Secretary
Elena Ridloff, CFA
Executive Vice President,
Chief Financial Officer
Kathie M. Bishop, Ph.D.
Senior Vice President, Head of Rare Disease
Daryl DeKarske
Senior Vice President, Global Head of Regulatory Affairs and Head of Translational Sciences
Stephanie Fagan
Senior Vice President Corporate Affairs and Chief Communications Officer
Charmaine Lykins
Senior Vice President, Global Product Planning and Chief Marketing Officer
Bob Mischler
Senior Vice President, Strategy and Technology Operations
Amanda Morgan
Senior Vice President, Chief Revenue and Customer Officer
Diann Potestio
Senior Vice President, Global Market Access, Reimbursement & Distribution
Eliseo Salinas, M.D., M.Sc.
Senior Vice President, Chief Scientific Officer and Head of External Innovation
Mark Schneyer
Senior Vice President, Business Development and Chief Business Officer
Ponni Subbiah, M.D., M.P.H.
Senior Vice President, Global Head of Medical Affairs and Chief Medical Officer
Brendan Teehan
Senior Vice President, Chief Insights & Analytics Officer
Mary Ellen Turner, M.D., M.P.H.
Senior Vice President, Pharmacovigilance and Corporate Safety Officer